Importance of surgery as salvage treatment after high dose chemotherapy failure in germ cell tumors

Journal of Urology

Volumn 165, Issue 6 I, 2001, Pages

  Flechon A ^a   Rivoire, M ^a   Biron, P ^a   Droz, J P ^a  

^a CENTRE LÉON BÉRARD   (France)

Author keywords

Drug therapy; Germinoma; Mediastinum; Salvage therapy; Testes

Indexed keywords

ALPHA FETOPROTEIN; BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE; LACTATE DEHYDROGENASE; METHOTREXATE; NAVELBINE; PACLITAXEL; THIOTEPA; TUMOR MARKER; VINCRISTINE; ANTINEOPLASTIC AGENT; CARBOPLATIN;

ADOLESCENT; ADULT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; GERM CELL TUMOR; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MULTIMODALITY CANCER THERAPY; PRIORITY JOURNAL; SALVAGE THERAPY; TREATMENT FAILURE; DISEASE COURSE; METASTASIS; MIDDLE AGED; PATHOLOGY; RETROSPECTIVE STUDY; TESTIS TUMOR;

ADOLESCENT; ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; GERMINOMA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SALVAGE THERAPY; TESTICULAR NEOPLASMS; TREATMENT FAILURE;

EID: 0034986311     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-5347(05)66243-X     Document Type: Article

References (38)

1. International germ cell consensus classification: A prognostic factor-based staging system for metastatic germ cell cancers
2. Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ-cell tumors: A southeastern cancer study group protocol
3. Treatment of disseminated germ-cell tumors with cisplatin, bleomycin and either vinblastine or etoposide
4. Vinblastine, plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ-cell tumor
5. High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ-cell tumors
6. Early intensified chemotherapy with autologous bone marrow transplantation in first-line treatment of poor-risk non-seminomatous germcell tumours: Preliminary results of a French randomized trial
7. High-dose chemotherapy as salvage treatment for germ cell tumors. The ongoing IT94 study
8. Tandem high-dose chemotherapy with autologous bone marrow transplantation for initial relapse of testicular germ-cell cancer
9. High-dose chemotherapy with hematopoietic stem-cell support in germ-cell tumor patient treatment: The French experience
10. Chemotherapy for germ cell tumors relapsing after high-dose chemotherapy and stem cell support: A retrospective multicenter study of the austrian study group on urologic oncology
11. Results of treatment after relapse from high-dose chemotherapy in germ cell tumors
12. Phase II trial of a combination of ifosfamide (I), navelbin (N), epirubicin (E), as salvage chemotherapy (CT) in refractory germ cell tumors (RGCT)
13. Maintenance chemotherapy with daily oral etoposide following salvage therapy in patients with germ cell tumors
14. Phase II study of daily oral etoposide in refractory germ cell tumors
15. Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors
16. Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
17. A phase II trial of paclitaxel in refractory germ cell tumors
18. Gemcitabine in patients with relapsed or cisplatin-refractory testicular cancer
19. Phase II trial of gemcitabine in refractory germ cell tumors
20. Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients
21. Paclitaxel and cisplatin as salvage treatment in patients with nonseminomatous germ cell tumour who failed to achieve a complete remission on induction chemotherapy
22. Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients
23. Is post chemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?
24. Decision analysis for avoiding postchemotherapy surgery in patients with disseminated nonseminomatous germ cell tumors
25. Adjunctive surgery after chemotherapy for non seminomatous germ cell tumors: Recommendations for patient selection
26. Resection of postchemotherapy residual masses and limited retroperitoneal lymphadenectomy in patients with metastatic testicular nonseminomatous germ cell tumors
27. Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: Multivariate analysis of individual patient data from six study groups
28. Validity of predictions of residual retroperitoneal mass histology in nonseminomatous testicular cancer
29. Sequential excision of residual thoracic and retroperitoneal masses after chemotherapy for stage III germ cell tumors
30. Combined postchemotherapy retroperitoneal lymph node dissection and resection of chest tumor under the same anesthetic is approprate based on morbidity and tumor pathology
31. Sequential resection of residual abdominal and thoracic masses after chemotherapy for metastatic non-seminomatous germ cell tumours
32. Post-chemotherapy tumor residuals in patients with advanced nonseminomatous testicular cancer. Is it necessary to resect all residual masses?
33. Outcome analysis for patients with persistent nonteratomatous germ cell tumor in postchemotherapy retroperitoneal lymph node dissections
34. Surgical salvage of chemorefractory germ cell tumors
35. Surgical resection of solitary metastasis after chemotherapy in patients with nonseminomatous germ cell tumors and elevated serum tumor markers
36. Surgical resection in patients with nonseminomatous germ cell tumor who fail to normalize serum tumor markers after chemotherapy
37. Surgery as salvage therapy in chemotherapy-resistant nonseminomatous germ cell tumours
38. Salvage surgery of chemorefractory germ cell tumors with elevated tumors markers